McKesson Corp. Stock Rating Reaffirmed by JPMorgan Chase & Co. (MCK)
McKesson Corp. (NYSE:MCK)‘s stock had its “overweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday, Analyst Ratings News reports. They currently have a $215.00 price target on the stock, up from their previous price target of $210.00. JPMorgan Chase & Co.’s price target would suggest a potential upside of 23.40% from the company’s current price.
A number of other analysts have also recently weighed in on MCK. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of McKesson Corp. in a research note on Tuesday. Separately, analysts at Bank of America reiterated an “underperform” rating on shares of McKesson Corp. in a research note on Tuesday. They now have a $165.00 price target on the stock, up previously from $160.00. Finally, analysts at ISI Group cut their price target on shares of McKesson Corp. from $212.00 to $204.00 in a research note on Tuesday. They now have a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. McKesson Corp. presently has an average rating of “Buy” and an average target price of $189.38.
McKesson Corp. (NYSE:MCK) traded up 2.92% on Tuesday, hitting $179.31. 2,057,095 shares of the company’s stock traded hands. McKesson Corp. has a 1-year low of $109.82 and a 1-year high of $188.02. The stock’s 50-day moving average is $170.6 and its 200-day moving average is $168.5. The company has a market cap of $41.264 billion and a price-to-earnings ratio of 35.38.
McKesson Corp. (NYSE:MCK) last posted its quarterly earnings results on Monday, May 12th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.40 by $0.15. The company had revenue of $38.14 billion for the quarter, compared to the consensus estimate of $35.89 billion. During the same quarter in the previous year, the company posted $1.45 earnings per share. The company’s revenue for the quarter was up 25.0% on a year-over-year basis. Analysts expect that McKesson Corp. will post $10.58 EPS for the current fiscal year.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.